Tauvega - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 24,865 | 24,790 | 25,015 | 29,383 | 36,500 | 39,640 | 41,970 | 29,131 |
| Profit before tax | - | - | - | - | - | 527 | - | - |
| Net profit | 539 | -2,074 | 2,799 | -3,113 | 1,805 | 527 | -730 | -8,457 |
| Equity | 3,535 | 1,461 | 4,260 | 1,147 | 2,953 | 3,480 | 2,749 | -5,708 |
| Liabilities | -117 | 188 | -679 | -268 | 137 | 115 | 108 | 8,840 |
| Non-current assets | 599 | 304 | 107 | 635 | 849 | 608 | 367 | 168 |
| Current assets | 2,819 | 1,345 | 3,474 | 244 | 1,662 | 2,408 | 1,911 | 2,385 |
| Total assets | 3,418 | 1,649 | 3,581 | 879 | 2,511 | 3,016 | 2,278 | 2,553 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,674 | 5,087 | 2,641 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -5.4% | -0.3% | +0.9% | +17.5% | +24.2% | +8.6% | +5.9% | -30.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 15.8% | -125.8% | 78.2% | -354.2% | 71.9% | 17.5% | -32.0% | -331.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 15.2% | -142.0% | 65.7% | -271.4% | 61.1% | 15.1% | -26.6% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.2% | -8.4% | 11.2% | -10.6% | 4.9% | 1.3% | -1.7% | -29.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | 1.3% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 | - | - | 0.0 | 0.0 | 0.0 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,288 | 8,263 | 8,338 | 9,794 | 12,167 | 13,213 | 13,990 | 10,593 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Tauvega - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 0.03 |
| 2026-06-16 | 2026-06-22 | 0.03 |
| 2025-11-18 | 2025-11-27 | 0.03 |
| 2025-10-23 | 2025-10-30 | 0.03 |
| 2025-09-16 | 2025-09-23 | 13.79 |
| 2025-03-18 | 2025-03-30 | 1.15 |
Tauvega - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Tauvega, UAB (code 300069978) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €29.1K, down 30.6% year on year and 26.5% over two years. Net result for 2025 was a loss of €8.5K, corresponding to a -29.0% profit margin, after a smaller loss of €730 in 2024 and a modest profit of €527 in 2023. This shows a clear deterioration in profitability over the latest three-year period. At the end of 2025, total assets stood at €2.6K, with equity at -€5.7K and liabilities at €8.8K. Current assets were €2.4K and long-term assets €168. Asset turnover was high at 11.41x, reflecting revenue generation relative to a very small asset base. Revenue per employee was €14.6K, while profit per employee was negative at €4.2K. Overall, the 2025 figures indicate weaker trading activity and a strained balance sheet compared with the previous years.